Cargando…
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
Phosphatidylinositol 3-kinase signaling promotes cell growth and survival and is frequently activated in infiltrative gliomas. Activating mutations in PIK3CA gene are observed in 6–15% of glioblastomas, although their clinical significance is largely undescribed. The objective of this study was to e...
Autores principales: | Tanaka, Shota, Batchelor, Tracy T., Iafrate, A. John, Dias-Santagata, Dora, Borger, Darrell R., Ellisen, Leif W., Yang, Daniel, Louis, David N., Cahill, Daniel P., Chi, Andrew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487518/ https://www.ncbi.nlm.nih.gov/pubmed/31036078 http://dx.doi.org/10.1186/s40478-019-0720-8 |
Ejemplares similares
-
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
por: Dias-Santagata, Dora, et al.
Publicado: (2011) -
Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy
por: Tanaka, Shota, et al.
Publicado: (2019) -
Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells
por: Weber, Genevieve L., et al.
Publicado: (2011) -
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
por: Dias-Santagata, Dora, et al.
Publicado: (2010) -
Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)